- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: pegylated liposomal Doxorubicin (CAELYX) & Carboplatin
Total 1306 results
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
Aprea TherapeuticsCompletedHigh-grade Serous Ovarian CancerSpain, United Kingdom, Belgium
-
The Netherlands Cancer InstituteUnknownMeningeal CarcinomatosisNetherlands
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedCervical CancerUnited States, Norway
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedSarcomaUnited States
-
Centocor, Inc.Completed
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Medical University InnsbruckUnknown
-
CelgeneGynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Peking University People's HospitalXijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaboratorsWithdrawnToxicity | Overall Survival | Progression-free SurvivalChina
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
Joseph TuscanoMillennium Pharmaceuticals, Inc.CompletedAcute Myelogenous LeukemiaUnited States
-
Merck Sharp & Dohme LLCEssex Pharma GmbHCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of Texas Southwestern Medical CenterOrtho Biotech Clinical Affairs, L.L.C.WithdrawnOvarian CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
InxMed (Shanghai) Co., Ltd.Recruiting
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLCCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); NYU Langone Health and other collaboratorsCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute, NaplesActive, not recruitingOvarian CancerItaly, Portugal, Turkey
-
AGO Study GroupMerck Sharp & Dohme LLCCompletedCarcinosarcoma | Leiomyosarcoma | Mesenchymal TumorGermany
-
PfizerTerminatedOvarian Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Ovarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
PharmaMarCompletedOvarian CancerUnited States
-
Grupo Español de Investigación en Cáncer de OvarioPharmaMarCompleted
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCWithdrawnStudy of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple MyelomaMultiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownAdult Acute Lymphoblastic LeukemiaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCSPC Ouyi Pharmaceutical Co., Ltd.Recruiting
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Hoosier Cancer Research NetworkBoehringer IngelheimTerminated
-
Roswell Park Cancer InstituteCompleted
-
European Organisation for Research and Treatment...Completed
-
SOLTI Breast Cancer Research GroupCompleted
-
French Innovative Leukemia OrganisationCompleted
-
ARCAGY/ GINECO GROUPPharmaMarCompletedOvarian CancerFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ortho Biotech, Inc.Completed
-
SanofiCompletedNeoplasm MalignantUnited States
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Triple Negative Breast CancerUnited States
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
University of IowaAventis PharmaceuticalsTerminatedPancreatic CancerUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingRecurrent, Platinum-resistant Ovarian CancerItaly